Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 1/20 | 0.71 |
| ▸ | CTSB | P07858 | 1/20 | 0.71 |
| ▸ | MMP9 | P14780 | 1/20 | 0.71 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.71 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.71 |
| ▸ | DNMT3L | Q9UJW3 | 1/20 | 0.71 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.71 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.65 |
| ▸ | LCK | P06239 | 2/20 | 0.65 |
| ▸ | HNF4A | P41235 | 1/20 | 0.62 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.57 |
| ▸ | EGFR | P00533 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9769838 | 0.87 | KLKB1 (0.56) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL2534915 | 0.85 | KAT8 (0.76) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL9769857 | 0.84 | KLKB1 (0.53) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL925372 | 0.84 | TRPA1 (0.57) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL2126940 | 0.84 | PPARA (0.65) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL1287171 | 0.83 | ALDH1A1 (0.54) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL160646 | 0.83 | KLKB1 (1.00) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL29414416 | 0.83 | KLKB1 (1.00) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL10950033 | 0.83 | LCK (0.89) | KLKB1CTSBMMP9DNMT1DNMT3B | |
| SCHEMBL1913451 | 0.82 | TRPA1 (0.55) | KLKB1CTSBMMP9DNMT1DNMT3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120015772-A | Negative pole piece, battery, energy storage device and electric equipment | 深圳海辰储能科技有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-1101180-C | Cosmetics and/or composition for treating skin disease and use thereof | OREAL (FR) | 2003-02-12 | — | — | CN | claimed |
| EP-0987011-B1 | Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use | OREAL (FR) | 2002-07-17 | — | — | EP | claimed |
| US-6281203-B1 | ESTER OF A FATTY ACID AND GLUCOSE AND/OR ALKYLGLUCOSE, AND AN OXYETHYLENATED ETHER OF A FATTY ACID ESTER OF GLUCOSE AND/OR ALKYLGLUCOSE. | L'OREAL (FR) | 2001-08-28 | — | — | US | claimed |
| CN-1245054-A | Cosmetics and/or composition for treating skin disease and use thereof | OREAL (FR) | 2000-02-23 | — | — | CN | claimed |
| US-12398097-B2 | WDR5-MYC inhibitors | VANDERBILT UNIVERSITY (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250162979-A1 | P-DIPHENYL COMPOUND DERIVATIVE MIXTURE AND METHOD OF PRODUCING THE SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2025-05-22 | — | — | US | disclosed |
| CN-120015772-A | Negative pole piece, battery, energy storage device and electric equipment | 深圳海辰储能科技有限公司 | 2025-05-16 | — | — | CN | disclosed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4501897-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| CN-1155103-A | Toner for electrostatic image developing and electric-charge controlling agent thereof | CANON KK (JP) | 1997-07-23 | — | — | CN | disclosed |
| US-5580549-A | BLEACHING; 2-HYDROXYBENZOIC ACID COMPOUND | SHISEIDO CO., LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
| US-5382560-A | Metal salt of styrene-salicyclic acid compound | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-17 | — | — | US | disclosed |
| EP-0570230-A1 | External preparation for skin | SHISEIDO COMPANY LIMITED (JP) | 1993-11-18 | — | — | EP | disclosed |
| EP-0547629-A1 | Color developers and sheets thereof | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1993-06-23 | — | — | EP | disclosed |
| EP-0419659-A1 | COLOR DEVELOPER FOR PRESSURE-SENSITIVE RECORDING MEDIUM, AQUEOUS DISPERSION OF COLOR DEVELOPER, AND PROCESS FOR ITS PREPARATION | ARAKAWA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-04-03 | — | — | EP | disclosed |
| US-4131682-A | Heteroaryl ketone derivatives | LILLY INDUSTRIES LIMITED (GB) | 1978-12-26 | — | — | US | disclosed |
| US-4111998-A | CATALYTIC REDUCTION, PALLADIUM CATALYST | RHONE-POULENC S.A. (FR) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | CYP4F2, DUOX1, BCKDK | KLKB1 829/4885CTSB 3569/4885MMP9 4014/4885 |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | KLKB1 645/4885CTSB 1325/4885MMP9 2523/4885 |
| US-20250162979-A1 | P-DIPHENYL COMPOUND DERIVATIVE MIXTURE AND METHOD OF PRODUCING THE SAME | DDT, CYP2D6, CYP3A4 | KLKB1 4168/4885CTSB 3635/4885MMP9 3404/4885 |
| US-12398097-B2 | WDR5-MYC inhibitors | MYC, WDR5, MYCBP | KLKB1 4848/4885CTSB 4461/4885MMP9 3801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.